Esperion Therapeutics, Inc. (ESPR)

Esperion Therapeutics Revenue

Esperion Therapeutics had revenue of $87.31M in the quarter ending September 30, 2025, with 69.10% growth. This brings the company's revenue in the last twelve months to $303.80M, up 2.83% year-over-year. In the year 2024, Esperion Therapeutics had annual revenue of $332.31M with 185.66% growth.

• Revenue (ttm): $303.80M
• Revenue Growth: +2.83%
• P/S Ratio: 2.07
• Revenue / Employee: $999,349
• Employees: 304
• Market Cap: 748.67M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	332.31M	215.98M	185.66%
Dec 31, 2023	116.33M	40.86M	54.14%
Dec 31, 2022	75.48M	-2.97M	-3.79%
Dec 31, 2021	78.45M	-149.10M	-65.52%
Dec 31, 2020	227.55M	79.18M	53.37%
Dec 31, 2019	148.36M	-	-
Dec 31, 2018	-	-	-
Dec 31, 2017	-	-	-
Dec 31, 2016	-	-	-
Dec 31, 2015	-	-	-
Dec 31, 2014	-	-	-
Dec 31, 2013	-	-	-
Dec 31, 2012	-	-	-
Dec 31, 2011	-	-	-